Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. announce the renewal of their chemistry services Agreement

March 2009
Chemical Business;Mar2009, Vol. 23 Issue 3, p71
Trade Publication
The article reports on the renewal of the Chemistry Services Agreement between Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Under the said Chemistry Services Agreement, Dalton will continue to offer chemistry services to show support for the pharmaceutical development programs of Boehringer. According to Dalton President Peter Pekos, the renewal of the agreement shows the deep dedication of Boehringer Ingelheim to research in Canada.


Related Articles

  • Dalton and Oncovir Enter Into a Manufacturing Services Agreement.  // Biomedical Market Newsletter;5/5/2011, p970 

    The article reports on the Manufacturing Services Agreement signed by Dalton Pharma Services and Oncovir Inc. in Toronto, Ontario. Under the agreement, Dalton will be providing aseptic fill/finish services for the production of immune activator Hiltonol by Oncovir. Peter Pekos, president and...

  • DALTON Pharma Services.  // Contract Pharma;2013 Corporate Capabilities & Contract Services Directory, p74 

    The article offers information on Dalton Pharma Services, provider of drug development, chemistry, and manufacturing services in the biotechnology and pharmaceutical industries based in Toronto, Ontario. It states that the customers of Dalton include a wide range of firms in the industries....

  • Takeda Buys ARIAD for $5.2 Billion.  // Contract Pharma;Jan/Feb2017, Vol. 19 Issue 1, p16 

    The article offers pharmaceutical industry news briefs as of January 2017 including acquisition of ARIAD Pharmaceuticals by Takeda Pharmaceutical; a validation laboratory opened by Sartorius Stedim Biotech (SSB); and an agreement of Dalton Pharma Services with Cerium Pharmaceuticals to focus on...

  • Dalton Expands Sterile Mfg. Capabilities.  // Contract Pharma;Mar2015, Vol. 17 Issue 2, p125 

    The article offers information on the expansion made by Dalton Pharma Services Inc. to its cGMP sterile powder filling capabilities with the addition of a high-speed automated sterile powder filling line to fill large commercial batches of vials.

  • STUDIES SHOW BENEFITS OF VACCINATING FOR CIRCOVIRUS. Desrosiers, Robert // National Hog Farmer;5/15/2007, Vol. 52 Issue 5, Special section p1 

    The article reports on the increasing incidence of porcine circovirus associated disease (PCVAD) on swines in the U.S. In response to this problem, many producers are taking a hard look at their disease management program inorder to reduce exposure, severity and mortality from the disease....

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;7/15/2006, Issue 1110, p2 

    This article regarding the decision of Boehringer Ingelheim Canada to issue a Dear Health Care Professional letter regarding the adverse effect of Aptivus. Boehringer Ingelheim has received reports of intracranial hemorrhage in patients with HIV-1 infection in its clinical trials.

  • ASK THE EXPERT. Filosa, Angelo // Lab Manager Magazine;May2013, Vol. 8 Issue 4, p36 

    An interview with Dr. Angelo Filosa, associate director in chemistry and head of analytical chemistry and compound management at Boehringer Ingelheim (Canada) Ltd. is presented. He shares about his work in drug discovery doing preclinical works that uses a number of ultrahigh-performance liquid...

  • Will CROs Take on the Risks of Strategic Outsourcing? Miller, Jim // Pharmaceutical Technology;Jun2004, Vol. 28 Issue 6, p70 

    The article discusses about outsourcing in pharmaceutical services. The issue debated was whether contract service providers can deliver the performance improvements and costs savings that drug companies expects from large, long-term, semi-excusive contracts. The issue was debated during the...

  • Dalton Initiates Sterile Filling Expansion.  // Contract Pharma;Mar2013, Vol. 15 Issue 2, p132 

    The article reports on the move of Dalton Pharma Services in starting the first stage of their plan to expand the manufacturing capabilities of aseptic filling.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics